<DOC>
	<DOCNO>NCT01227720</DOCNO>
	<brief_summary>Comparative pharmacokinetic study new oral nicotine replacement therapy product .</brief_summary>
	<brief_title>Comparative Pharmacokinetic Study New Oral Nicotine Replacement Therapy Products .</brief_title>
	<detailed_description>This study compare new oral Nicotine Replacement Therapy ( NRT ) product contain 2 4 mg nicotine NiQuitinâ„¢ lozenge 2 mg 4 mg , 12 hour nicotine abstinence , respect nicotine pharmacokinetics , 12 hour start administration . Single dose treatment A , B , C , D give morning separate treatment visit schedule crossover set randomize treatment sequence , also include fifth treatment visit either treatment E F. The study include 104 healthy smoker age 19 50 year , smoke least 10 cigarette daily least one year precede inclusion . The study perform two site 52 subject site . Subjects study personnel aware treatment administer give visit .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subject , smoke least 10 cigarette daily least one year precede inclusion BMI 17.5 30.0 kg/m2 . Female participant childbearing potential require use medically acceptable mean birth control . A personally sign date informed consent document , indicate subject inform pertinent aspect study . Pregnancy , lactation intend pregnancy . Treatment investigational product donation loss blood within 3 month precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Smoking Cessation , Nicotine pharmacokinetics</keyword>
</DOC>